Validation pour Ingenuity283

vers la météo de la validation par utilisateur

Ingenuity283

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 58 - PMID ?

In nuclei from male SP lung cells , intravenous administration of NODE ( with a dosage of 6 mg/kg ) decreases expression of SP NODE protein 2 hours after initial treatment .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             +---------------------------COMP:V-N(after)---------------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 1

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             +---------------------------COMP:V-N(after)---------------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 2

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             +---------------------------COMP:V-N(after)---------------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 3

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             +---------------------------COMP:V-N(after)---------------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 4

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+---------------------------COMP:V-N(after)---------------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 5

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+---------------------------COMP:V-N(after)---------------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 6

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+---------------------------COMP:V-N(after)---------------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 7

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+---------------------------COMP:V-N(after)---------------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 8

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |                                                                            
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 9

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |                                                                            
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 10

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |                                                                            
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 11

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |                                                                            
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 12

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+                                                                            
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 13

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+                                                                            
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 14

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |          +----------------------COMP:N-N(after)---------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 15

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |          +----------------------COMP:N-N(after)---------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 16

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+                                                                            
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 17

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+                                                                            
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 18

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |          +----------------------COMP:N-N(after)---------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 19

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |          +----------------------COMP:N-N(after)---------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 20

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+          +----------------------COMP:N-N(after)---------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 21

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+          +----------------------COMP:N-N(after)---------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 22

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+          +----------------------COMP:N-N(after)---------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 23

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+          +----------------------COMP:N-N(after)---------------------+      
       |          +--MOD_ATT:N-ADJ-+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-ADJ (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 24

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             +---------------------------COMP:V-N(after)---------------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 25

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             +---------------------------COMP:V-N(after)---------------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 26

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             +---------------------------COMP:V-N(after)---------------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 27

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             +---------------------------COMP:V-N(after)---------------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 28

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+---------------------------COMP:V-N(after)---------------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 29

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+---------------------------COMP:V-N(after)---------------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 30

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+---------------------------COMP:V-N(after)---------------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 31

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+---------------------------COMP:V-N(after)---------------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 32

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |                                                                            
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 33

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |                                                                            
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 34

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |                                                                            
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 35

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |                                                                            
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 36

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+                                                                            
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 37

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+                                                                            
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 38

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |          +----------------------COMP:N-N(after)---------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 39

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |          +----------------------COMP:N-N(after)---------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 40

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+                                                                            
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 41

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+                                                                            
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                     
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)-------+      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(after) (protein,treatment)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 42

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |          +----------------------COMP:N-N(after)---------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 43

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       +-------COMP:N-N(from)------+                                                                             |          +----------------------COMP:N-N(after)---------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
COMP:N-N(from) (nucleus,cell)
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 44

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+          +----------------------COMP:N-N(after)---------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 45

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+          +----------------------COMP:N-N(after)---------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 46

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+          +----------------------COMP:N-N(after)---------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 47

       +-----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                                            
       |                           +--------------------------------COMP:V-N(from)-------------------------------+          +----------------------COMP:N-N(after)---------------------+      
       |          +---MOD_ATT:N-N--+                        +----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                              |      
       |          |     +MOD_ATT:N-+                        |                       +------OBJ:V-N-----+         |          |           +-MOD_ATT:N-ADJ-+                              |      
       |          |     |     +MOD_+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N+   |         +--OBJ:V-N-+           |       +MOD_ATT+    +MOD+MOD:A+      +MOD_ATT:+      
       |          |     |     |    |          |             |              |        |       |      |   |         |          |           |       |       |    |   |     |      |        |      
 In nuclei from male __SP__ lung cells , intravenous administration of __NODE__ ( with a dosage of 6 mg/kg ) decreases expression of __SP__ __NODE__ protein 2 hours after initial treatment .
MOD_ATT:N-N (cell,male)
MOD_ATT:N-ADJ (cell,__SP__)
MOD_ATT:N-N (cell,lung)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,6)
COMP:V-N(In) (decrease,nucleus)
COMP:V-N(from) (decrease,cell)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (hour,2)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)